Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

15.29
+0.40002.69%
Post-market: 15.13-0.1620-1.06%19:40 EDT
Volume:5.40M
Turnover:81.85M
Market Cap:1.50B
PE:-2.62
High:15.52
Open:14.79
Low:14.43
Close:14.89
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:1.30
T/O Rate:6.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-5.17
PE(LYR):-2.62

Loading ...

Ultragenyx Hits Record Low After Rare Disease Drug Trial Failure

Reuters
·
Sep 03

Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?

TIPRANKS
·
Sep 03

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03

Ultragenyx price target lowered to $28 from $77 at Jefferies

TIPRANKS
·
Sep 03

Wedbush Keeps Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $33 from $103 at Cantor Fitzgerald

TIPRANKS
·
Sep 03

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

TIPRANKS
·
Sep 03

Ultragenyx Stock Sinks 47% on Drug Trial Failure. Why Wall Street Isn't Giving up Yet.

Dow Jones
·
Sep 03

U.S. Stocks on the MOVE-Snowflake, Ultragenyx Pharmaceutical, Broadcom

Reuters
·
Sep 03

Top Premarket Decliners

MT Newswires Live
·
Sep 03

Wedbush Adjusts Price Target on Ultragenyx Pharmaceutical to $23 From $30, Maintains Neutral Rating

MT Newswires Live
·
Sep 03

Canaccord Genuity Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $37 from $83 at Canaccord

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $25 from $50 at H.C. Wainwright

TIPRANKS
·
Sep 03

Stocks to Watch: Snowflake, Broadcom, HPE, Ultragenyx

Dow Jones
·
Sep 03

Ultragenyx Pharma is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Sep 03

Ultragenyx Pharmaceutical Shares Crash 45% After Angelman Syndrome Drug Trial Disappoints

Trading Random
·
Sep 03

Ultragenyx Pharmaceutical Inc. : Baird Cuts to Neutral Rating; Cuts Target Price to $16 from $40

THOMSON REUTERS
·
Sep 03

Ultragenyx Pharmaceutical Inc. : TD Cowen Cuts Target Price to $18 from $49

THOMSON REUTERS
·
Sep 03

Ultragenyx Pharmaceutical Inc. : Canaccord Genuity Cuts Target Price to $37 from $83

THOMSON REUTERS
·
Sep 03